193. Taking the Lead in Drug Interaction Prevention in Post-Acute and Long-Term Care Settings

2019 FNCE Sessions recordings

Drug nutrient interaction defines a physicochemical, physiological, or pathophysiological association between medications and nutrients.

  • SKU FNCE19193
Member Price
$24.00
Nonmember Price
$54.00

This products is free for those who attended FNCE® 2019.

Drug nutrient interaction defines a physicochemical, physiological, or pathophysiological association between medications and nutrients. These chemical reactions can contribute to malnutrition, interfere with medication therapy, and produce adverse events to include life threatening conditions. Furthermore, while micronutrient supplementation is warranted in those individuals who cannot meet their nutritional needs with food alone, the indiscriminate use of nutrient supplementation for disease prevention is not supported by the current scientific evidence.

Registered dietitian nutritionists must be poised to evaluate the benefits and adverse outcomes of nutrient/dietary supplementation. RDNs must coordinate with the interprofessional team which includes physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare providers to lessen drug nutrient interactions and adverse events.

Award Presentation: Excellence in Practice – DTR Award - Drisana Clifton, NDTR

Planned with the Dietetics in Health Care Communities DPG

CPEU: 1.5
CPE Level: 3 - Advanced
Learning Need Codes: 3070, 5040, 2090

Performance Indicators:

  • 10.4.3 Evaluates, educates and counsels on the interrelationship and impact of pharmacotherapy on nutrient absorption.
  • 8.1.3 Integrates knowledge of macronutrients and micronutrients for absorption, digestion and metabolism throughout the life span in practice.
  • 8.3.6 Keeps abreast of current nutrition and dietetics knowledge and trends.

Learning Objectives

  • Describe at least three clinically relevant drug-micronutrient interactions.
  • Evaluate the need and safety of micronutrient supplementation and its potential interaction with food, other dietary supplements, and over-the-counter and prescribed medications.
  • Identify opportunities, based on updated Center for Medicare and Medicaid Services' State Operations Manual F-Tags guidance, for the dietitian to partner with the pharmacist in the development of organization/provider-approved pharmacotherapy protocols for monitoring food/dietary supplement and drug interactions.

Moderator

  • Cora Martin, RDN, CSG, LD

Speakers

  • Jane Ziegler, DCN, RDN, LDN
  • Nicole Brandt, PharmD, MBA, BCGP, BCPP, FASCP
  • SKU FNCE19193